diphenyleneiodonium and candesartan

diphenyleneiodonium has been researched along with candesartan in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, J; Gessner, R; Köttgen, E; Niessen, H; Ohlemeyer, C; Roos, D; Wu, S	1

Other Studies

1 other study(ies) available for diphenyleneiodonium and candesartan

Article	Year
Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes. Free radical biology & medicine, 2005, Dec-15, Volume: 39, Issue:12 Topics: Acetylcysteine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Dose-Response Relationship, Drug; Heart Ventricles; HL-60 Cells; Humans; Myocytes, Cardiac; NADPH Oxidases; Onium Compounds; Oxidation-Reduction; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors; Transcription Factor AP-1	2005

Article

Year

Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes.

Free radical biology & medicine, 2005, Dec-15, Volume: 39, Issue:12

Topics: Acetylcysteine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Dose-Response Relationship, Drug; Heart Ventricles; HL-60 Cells; Humans; Myocytes, Cardiac; NADPH Oxidases; Onium Compounds; Oxidation-Reduction; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors; Transcription Factor AP-1

2005